MALTINTI, MARISTELLA
 Distribuzione geografica
Continente #
AS - Asia 1.317
NA - Nord America 838
SA - Sud America 276
EU - Europa 231
AF - Africa 36
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.701
Nazione #
US - Stati Uniti d'America 813
SG - Singapore 573
CN - Cina 285
BR - Brasile 219
VN - Vietnam 154
HK - Hong Kong 111
FR - Francia 70
KR - Corea 54
IT - Italia 37
JP - Giappone 37
NL - Olanda 34
AR - Argentina 24
GB - Regno Unito 20
DE - Germania 19
IN - India 19
BD - Bangladesh 18
FI - Finlandia 14
EC - Ecuador 13
IQ - Iraq 10
CA - Canada 9
MX - Messico 9
SA - Arabia Saudita 9
PL - Polonia 8
TR - Turchia 8
ZA - Sudafrica 8
ID - Indonesia 7
ET - Etiopia 5
IL - Israele 5
MA - Marocco 5
PK - Pakistan 5
PY - Paraguay 5
RU - Federazione Russa 5
TN - Tunisia 5
ES - Italia 4
KE - Kenya 4
PE - Perù 4
PH - Filippine 4
UA - Ucraina 4
VE - Venezuela 4
AM - Armenia 3
AZ - Azerbaigian 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CL - Cile 2
DZ - Algeria 2
JM - Giamaica 2
KZ - Kazakistan 2
NP - Nepal 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
JO - Giordania 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.701
Città #
Santa Clara 391
Singapore 335
Hong Kong 110
Beijing 90
Hefei 82
San Jose 65
Lauterbourg 64
Ashburn 55
Seoul 54
Ho Chi Minh City 50
Los Angeles 48
Hanoi 39
Tokyo 32
Dallas 21
São Paulo 16
Helsinki 13
Buffalo 11
Cascina 10
New York 9
Frankfurt am Main 8
Guangzhou 8
Brooklyn 7
Houston 7
Atlanta 6
Buenos Aires 6
Rio de Janeiro 6
Warsaw 6
Addis Ababa 5
Bengaluru 5
Da Nang 5
Jeddah 5
Orem 5
Phoenix 5
Thái Nguyên 5
Amsterdam 4
Bauru 4
Biên Hòa 4
Campinas 4
Ciudad del Este 4
Denver 4
Düsseldorf 4
Florianópolis 4
Haiphong 4
Hải Dương 4
Johannesburg 4
London 4
Minamishinagawa 4
Nairobi 4
Ninh Bình 4
Quận Một 4
Ankara 3
Baghdad 3
Baku 3
Brasília 3
Bắc Ninh 3
Cairo 3
Dhaka 3
Falkenstein 3
Lima 3
Manchester 3
Milan 3
Porto Alegre 3
Recife 3
Salto 3
Yerevan 3
Almaty 2
Anápolis 2
Athens 2
Bardejov 2
Belfast 2
Cajamar 2
Campina Grande 2
Campos dos Goytacazes 2
Casablanca 2
Caxias do Sul 2
Charleston 2
Chennai 2
City of London 2
Curitiba 2
Dammam 2
Faisalabad 2
Fortaleza 2
Goiânia 2
Greensboro 2
Guarujá 2
Guayaquil 2
Hyderabad 2
Jakarta 2
Juiz de Fora 2
Kathmandu 2
Kingston 2
Lấp Vò 2
Marabá 2
Mexico City 2
Montreal 2
Munich 2
Nam Định 2
New Delhi 2
Pelotas 2
Phủ Lý 2
Totale 1.763
Nome #
Osteopontin: a possibile marker of vascular damage 82
Myocardial C-type natriuretric peptide in an experimental model of pacing-induced heart failure 79
Biochemical markers of inflammation, remodeling and apoptosis in an ex-vivo model of human saphenous vein graft neointimal hyperplasia. 74
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study 68
Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal 64
Vasoactive Factors In Chronic Liver Disease. 53
Determination of adiponectin multimers in human circulation 52
Human heart-type fatty acid-binding proteina s an early marker of myocardial damage after radiofrequency ablation of tachyarrhythmias. 52
Human eart-type fatty acid -binding protein as an early marker of myocardial damageafte radiofrequency ablation of tachyarrhythmias. 52
Matrix metalloprotease-2 and -9 concentration and activity in culture medium and serum samples: methodological evaluation of two different methods 49
Direct assay for NT-proCNP determination: relationship with CNP. 47
High molecular weight adiponectin is increased in plasma of patients with idiopathic dilated cardiomyopathy with and without over heart failure. 47
Osteopontin plasma levels are elevated in patients with chronic heart failure in relation to clinical severity and cytokine expression. 45
Osteopontin: A possible marker of vascular damage. 45
Relationship between Bone Health Biomarkers and Cardiovascular Risk in a General Adult Population. 45
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa 44
RELATIONSHIP BETWEEN CNP AND NT-PROCNP ASSAY IN DISEASES CHARACTERIZED BY ENDOTHELIAL DYSFUNCTION 44
The role of C-type natriuretic peptide in the heart: study in an experimental model of pacing-induced heart failure. 43
Circulating adrenomedullin levels are related to Doppler-derived dP/dt in idopathic cardiomyopathy. 43
Adiponectin circulating levels: A new emerging biomarker of cardiovascular risk 43
Comparison of different immunoassays for total adiponectin in human plasma of patients with dilated cardiomyopathy cardiometabolic biomarkers in a swine model of myocardial infarction 43
Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. 42
L'adiponectina: un nuovo indicatore di rischio casrdiovascolare 41
NO-donor reduces osteopontin mrna expression in an human ex-vivo model of intimal hyperplasia 41
Plasma levels of big-endothelin-1 in cardiovascular and hepatic disorders. 41
Human heart-type fatty acid-binding protein is an early and sensitive marker of myocardial injury in patients undergoing radiofrequency ablation. 41
Osteopontin is produced by cultured human saphenous veins as a function of intima hyperplasia 40
Circulating adrenomedullin levels and Doppler-derived dP/dt in idiopathic cardiomyopathy. 40
Nuovi marcatori di funzione cardiaca: focus sul peptide natriuretico di tipo C (Rassegna) 40
Plasma adrenomedullin, BNP, NT-proBNP and dp/dt max in patients with chronic heart failure. 39
mRNA expression in myocardial tissue of CNP, BNP and their main receptors NPR-B and NPR-A: a methodological assessment 39
Increase plasma levels of osteopontin are related with coronary microvascular impairment in patients with idiopathic left ventricular dysfunction. 39
C-type natriuretic peptide increases in patients with idiopathic dilated cardiomyoapathy with or without overt heart failure 39
Direct assay for NT-proCNP determination: relationship with CNP. 38
Adiponectin mediates he effects of cardiometabolic risk profile on the coronary microcirculation in patients with idiopathic LV systolic dysfunction. 37
Plasma adiponectin and functional, inflammatory and metabolic markers in patients with dilated cardiomyopathy 37
Cardiac production of C-type natriuretic peptide in heart failure 37
Biological markers of vascular injury and gas exange impairment in chronic hepatic diseases. 36
C-Type natriuretic peptide (CNP) and NT-Pro-CNP in Raynaud's phenomenon: disease severity markers? 36
Laboratory evaluation of inflammatory reaction following percutaneous transluminal coronary angioplasty (PTCA). 36
Plasmatic Levels Of Cardiac Natriuretic Hormones In Healthy Adults: Effects Of Age And Sex. 36
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa and its homology with mouse 35
Methodological Evaluation of a Radioimmunological Assay For Plasma C-Type Natriuretic Peptide Determination 35
Osteopontin and interleukin-6 as markers of restenosis after coronary angioplasty? 34
Livelli plasmatici di adrenomedullina in pazienti con insufficienza renale prima e dopo emodialisi 34
Measurement of adiponectin and its multimers in human plasma: a methodological reappraisal 32
Circulating antibodies to heat shock proteins and biomarkers in patients with heart failure. 32
mRNA expression in myocardial tissue of CNP, BNP and its main receptors NPR-B and NPR-A: a methodological assessment 32
C-type natriuretic peptide plasma levels and chronic heart failure. 31
Effects of aging and anti-aging cloric restrictions on carbonyl and heal shock protein levels and expression 31
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa and its homology with mouse. 31
Myocardial C-type natriuretic peptide in an experimental model of pacing-induced heart failure. 30
Osteopontin plasma levels and coronary microvascular dysfunction in patients with idiopathic dilated cardiomyopathy 30
Circulating levels of adiponectin increase in patients with idiopathic dilated cardiomyopathy with and without overt heart failure 30
C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity 30
Livelli plasmatici di adrenomedullina in pazienti con insufficienza renale prima e dopo emodialisi. 29
New And Old Markers Of Chronic Heart Failure. 29
Radioimmunoassays for plasma C-type natriuretic peptide determination: a methodological evaluation 29
Peptide natriuretico C nel fenomeno di Raynaud: un marcatore di severità? 29
Cardiac production of C-type natriuretic peptide in heart failure. 29
Plasma adiponectin assay: methodological comparison of thre kit methods. 26
Increased levels of C-type natriuretic peptide in patients with dilated cardiomyopathy without overt heart failure. 26
Biochemical markers of inflammation remodeling and apoptosis in an ex-vivo model of human saphenous vein graft neointima hyperplasia. 25
NT-proCNP in Chronic Heart Failure: relationship with CNP. 25
Plasma levels of adrenomedullin, big-endothelin-1 and osteopontin in chronic heart failure. 25
Measurement of C-type natriuretic peptide: a methodological evaluation. 25
Effect of age on endothelin-1 receptors in rat cardiac membranes. 24
Methodological evaluation of an enzyme-immunoassay for plasma Big-et-1 determination 23
Increased plasma osteopontin levels in patients with heart failure. 22
Totale 2.702
Categoria #
all - tutte 7.889
article - articoli 7.547
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 113
Totale 15.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202438 0 0 0 0 0 0 0 0 1 0 37 0
2024/20251.097 1 5 113 39 307 83 19 25 37 45 220 203
2025/20261.567 69 131 124 264 375 101 230 64 78 74 57 0
Totale 2.702